Entity

Time filter

Source Type


Beta M.,Kamalnayan Bajaj Research Institute | Beta M.,SASTRA University | Venkatesan N.,Kamalnayan Bajaj Research Institute | Venkatesan N.,Birla Institute of Technology and Science | And 4 more authors.
Bioinformatics and Biology Insights | Year: 2013

Retinoblastoma (RB) is a malignant tumor of the retina seen in children, and potential non invasive biomarkers are in need for rapid diagnosis and for prognosticating the therapy. This study was undertaken to identify the differentially expressed miRNAs in the serum of children with RB in comparison with the normal age matched serum, to analyze its concurrence with the existing RB tumor miRNA profile, to identify its novel gene targets specific to RB, and to study the expression of a few of the identified oncogenic miRNAs in the advanced stage primary RB patient's serum sample. MiRNA profiling was performed on 14 pooled serum from chil- dren with advanced RB and 14 normal age matched serum samples, wherein 21 miRNAs were found to be upregulated (fold change ≥ +2.0, P ≤ 0.05) and 24 to be downregulated (fold change ≤ -2.0, P ≤ 0.05). Furthermore, intersection of 59 significantly deregulated miRNAs identified from RB tumor profiles with that of miRNAs detected in serum profile revealed that 33 miRNAs had followed a similar deregulation pattern in RB serum. Later we validated a few of the miRNAs (miRNA 17-92) identified by microarray in the RB patient serum samples (n = 20) by using qRT-PCR. Expression of the oncogenic miRNAs, miR-17, miR-18a, and miR-20a by qRT-PCR was signifcant in the serum samples exploring the potential of serum miRNAs identification as noninvasive diagnosis. Moreover, from miRNA gene target prediction, key regulatory genes of cell proliferation, apoptosis, and positive and negative regulatory networks involved in RB progression were identified in the gene expression profile of RB tumors. Therefore, these identified miRNAs and their corresponding target genes could give insights on potential biomarkers and key events involved in the RB pathway. © the author(s), publisher and licensee Libertas Academica Ltd. Source


Subramanian N.,Kamalnayan Bajaj Research Institute | Subramanian N.,Deakin University | Sreemanthula J.B.,Kamalnayan Bajaj Research Institute | Balaji B.,Andhra University | And 3 more authors.
Chemical Communications | Year: 2014

For the first time, a novel EpCAM aptamer (SYL3C)-DIBO-AF594 fluorescent conjugate was synthesised by bioorthogonal chemistry utilizing a strain promoted alkyne-azide cycloaddition (copper free click) reaction (SPAAC). The ligation efficiency of SPAAC was improved by freeze-thaw cycles. The obtained conjugate showed target specific binding and aided in the imaging of various EpCAM positive cancer cell lines like MCF7, MDAMB453, Weri-RB1 and PC3. © 2014 the Partner Organisations. Source


Subramanian N.,Kamalnayan Bajaj Research Institute | Sreemanthula J.B.,Kamalnayan Bajaj Research Institute | Balaji B.,Kamalnayan Bajaj Research Institute | Kanwar J.R.,Kamalnayan Bajaj Research Institute | And 2 more authors.
Chemical communications (Cambridge, England) | Year: 2014

For the first time, a novel EpCAM aptamer (SYL3C)-DIBO-AF594 fluorescent conjugate was synthesised by bioorthogonal chemistry utilizing a strain promoted alkyne-azide cycloaddition (copper free click) reaction (SPAAC). The ligation efficiency of SPAAC was improved by freeze-thaw cycles. The obtained conjugate showed target specific binding and aided in the imaging of various EpCAM positive cancer cell lines like MCF7, MDAMB453, Weri-RB1 and PC3. Source

Discover hidden collaborations